Company: FCRX
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0000950170-25-023153
Chunk: 350

Company: Crescent Capital BDC, Inc.
Filing Date: 2025-02-19
Form: 10-K
Item: Item 1B
Chunk 350
---
 provided by (used for) financing activities

    (43,470
    )

    (84,987
    )

    (34,405
    )

    Effect of exchange rate changes on cash denominated in foreign currency

    (485
    )

    92

    (5
    )

    Net increase (decrease) in cash, cash equivalents, restricted cash and foreign currency

    14,952

    7,403

    (6,459
    )

    Cash, cash equivalents, restricted cash and foreign currency, beginning of period

    24,470

    17,067

    23,526

    Cash, cash equivalents, restricted cash and foreign currency, end of period(1)
     
    $
    39,422

    $
    24,470

    $
    17,067

    Supplemental and non-cash financing activities:

    Cash paid during the period for interest
     
    $
    60,436

    $
    55,498

    $
    26,903

    Cash paid during the period for taxes
     
    $
    1,342

    $
    665

    $
    1,974

    Accrued but unpaid distributions
     
    $
    15,566

    $
    15,195

    $
    12,664

    Issuance of shares in connection with asset acquisition (Note 13)

    —

    $
    91,257

    —

    Deemed contribution from the Adviser (non-cash) (Note 13)

    —

    $
    22,040

    —

77

(1)As of December 31, 2024, the balance included cash and cash equivalents of $10,130 (including cash denominated in foreign currency of $692) and restricted cash and cash equivalents of $29,292 (including cash denominated in foreign currency of $13,514. As of December 31, 2023, the balance included cash and cash equivalents of $7,780 (including cash denominated in foreign currency of $1,728) and restricted cash and cash equivalents of $16,690 (including cash denominated in foreign currency of $692). 

(2)On March 9, 2023, in connection with the FCRD Acquisition (as defined in Note 1 and further discussed in Note 13), the Company acquired